Factory 99% Everolimus CAS 159351-69-6 Chemical Intermediate Anti-Cancer Everolimus

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A415
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Everolimus
• CAS: 159351-69-6
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Anti-Cancer
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Everolimus
Appearance	White Powder
CAS NO.	159351-69-6
Molecular Formula	C53H83NO14
Storage	Keep in a cool, dry, dark location

 

Everolimus, also known as RAD001, is a derivative of sirolimus (rapamycin). It is a pharmacological agent that functions as an mTOR (mammalian target of rapamycin) inhibitor.

 

 

1. Immunosuppression: Everolimus is primarily used in immunosuppressive therapy to prevent rejection in patients undergoing organ transplantation. It helps to reduce the immune system's attack on the transplanted organ.
2. Cancer Treatment: It has also been investigated and approved for use in certain types of cancer, particularly those that are sensitive to mTOR inhibition, such as advanced renal cell carcinoma and breast cancer.
3. Research and Clinical Trials: Everolimus continues to be studied in various clinical trials for its potential therapeutic benefits in other medical conditions.

1. Inhibition of mTOR Signaling: By inhibiting the mTOR pathway, Everolimus disrupts the cell cycle and inhibits cell growth and proliferation, which is particularly effective in treating certain cancers.
2. Immunoregulation: It exerts its immunosuppressive effects by forming inhibitory complexes with FKBP-12, thereby modulating the immune response and reducing the risk of organ rejection in transplant patients.
3. Antiproliferative Effects: In addition to its use in cancer treatment, Everolimus's antiproliferative properties make it a potential therapeutic option for other proliferative disorders, such as those involving abnormal cell growth.